Skip to main content
Earnings Labs
Immatics N.V. logo

Immatics N.V. (IMTX)

NASDAQ·Healthcare·Biotechnology

$9.66

+6.27%

Mkt Cap $1.26B

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (6 analysts)

$21.00

Range $17.00$25.00

Implied Upside

+117.4%

Consensus $21.00 vs current $9.66